CReST2 is a blinded, multi-centre randomised controlled trial with a 12 month internal feasibility to assess recruitment viability. It is designed to compare the effect of uncovered and covered stents on the quality of life of people with inoperable obstructing colorectal cancer who are managed by undertaking an urgent decompression and stenting.
Objectives
To compare the effect of uncovered and covered stents on the quality of life of people with inoperable obstructing colorectal cancer who are managed by undertaking an urgent decompression and stenting.
Participant Population and Sample Size
A minimum of 350 patients with colorectal cancer who are managed with a palliative intent and who require an urgent decompression of their colorectal obstruction. These participants will be recruited from a minimum 20 NHS sites across the UK and overseas.
Outcome Measures
Primary outcome: